Edurant
Edurant is an originator product from Janssen-Cilag AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 334.80 to CHF 334.80 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Janssen-Cilag AG
- ATC code
- J05AG05
- IT group
- 08.03 Mittel gegen Viren
- Active substances
- Rilpivirinum
- Preparation type
- Originator product
- On the SL since
- 01/07/2016
- Last price change
- 01/07/2016
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Filmtabl 25 mg | 30 Stk | CHF 292.74 | CHF 334.80 | 01/07/2016 | A | 7680615480010 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Edurant wird in Kombination mit anderen antiretroviralen Arzneimitteln für die Behandlung einer HIV-1 Infektion (Humanes Immundefizienz-Virus Typ 1) bei antiretroviral therapienaiven erwachsenen Patienten mit einer Viruslast von ≤100'000 HIV-1 RNA Kopien/ml vergütet.
Pädiatrische Patienten (12 bis 17 Jahre)
Edurant wird in Kombination mit anderen antiretroviralen Arzneimitteln für die Behandlung einer HIV-1 Infektion bei antiretroviral therapienaiven pädiatrischen Patienten von 12 bis 17 Jahren mit einer Viruslast von ≤100'000 HIV-1 RNA Kopien/ml vergütet, wenn andere alternative Therapien infolge Resistenzmutationen, bekannten Allergien oder vermuteten Unverträglichkeiten nicht in Frage kommen.
More preparations in this group
FAQ
Is Edurant covered by Swiss health insurance?
Yes, but only under conditions. Edurant is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Edurant cost in Switzerland?
The public price is the maximum price set by the FOPH and for Edurant ranges from CHF 334.80 to CHF 334.80 per pack. The ex-factory price ranges from CHF 292.74 to CHF 292.74. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages